The stronger Wegovy dose could see more than 20 per cent weight loss in patients with obesity
Notifications can be managed in browser preferences.
Swipe for next article
The stronger Wegovy dose could see more than 20 per cent weight loss in patients with obesity
Removed from bookmarks
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
Wegovy is approved on the NHS to help people lose weight in higher doses
Health secretary Wes Streeting wants to make the drugs more widely available on the NHS
Patients may eventually access weight-loss jabs at pharmacies in a drive to ‘turn the tide’ on rising obesity, Professor Sir…
GLP-1 users likely to regain two-thirds of the weight they lost within a year, study shows
The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.
At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions
